Moderna公司高管在电话会议中表示,公司正积极争取其流感与新冠联合疫苗在今年内获得欧洲监管机构的批准。
这一表态凸显了Moderna在推进组合疫苗商业化进程中的关键步伐,若顺利获批,将有望为欧洲地区提供更高效的呼吸道疾病防护方案。
Moderna公司高管在电话会议中表示,公司正积极争取其流感与新冠联合疫苗在今年内获得欧洲监管机构的批准。
这一表态凸显了Moderna在推进组合疫苗商业化进程中的关键步伐,若顺利获批,将有望为欧洲地区提供更高效的呼吸道疾病防护方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.